Back
SPDR S&P Global Dividend ETF Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Buy
63
WDIV
SPDR S&P Global Dividend ETF
Last Price:
$75.77
Seasonality Move:
0.82%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Buy
63
SPDR S&P Global Dividend ETF (WDIV)
is a Buy
Is SPDR S&P Global Dividend ETF a Buy, Sell or Hold?
-
The current SPDR S&P Global Dividend ETF [WDIV] share price is $75.48. The Score for WDIV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
WDIV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.59. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WDIV Stock Price Chart
What is SPDR S&P Global Dividend ETF's stock price today?
-
The SPDR S&P Global Dividend ETF share price today is $75.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WDIV is experiencing selling pressure, which indicates risk of future bearish movement.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
WDIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.18 | Buy |
| Relative Strength Index (14 RSI): | 62.06 | Buy |
| Chaikin Money Flow: | -18784 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.9 - 75.36) | Buy |
| Bollinger Bands (100): | (72.09 - 74.43) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.85 | Buy |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -1420728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.45 - 47.99) | Sell |
| Bollinger Bands (100): | (29.17 - 43.09) | Buy |
WDIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.34 | Buy |
| 20-day SMA: | 74.85 | Buy |
| 50-day SMA: | 73.92 | Buy |
| 200-day SMA: | 70.59 | Buy |
| 8-day EMA: | 39.93 | Buy |
| 20-day EMA: | 19.56 | Buy |
| 50-day EMA: | 8.53 | Buy |
| 200-day EMA: | 2.23 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Sell |
| 20-day SMA: | 45.09 | Sell |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 27.66 | Buy |
| 8-day EMA: | 22.1 | Buy |
| 20-day EMA: | 10.83 | Buy |
| 50-day EMA: | 4.72 | Buy |
| 200-day EMA: | 1.23 | Buy |
SPDR S&P Global Dividend ETF Earnings Growth & WDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
SPDR S&P Global Dividend ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||